Comparison of clinical therapeutic effect between Sanjiezhentong capsule per oral and Mifepristone in treatment of endometriosis after laparoscopic conservative surgery

In: Journal of laparoscopic surgery · 2010 · W2364786962
article OA: closed CC0
View on OpenAlex

Abstract

Objective:To compare the therapeutic efficacy of Sanjiezhentong capsule and Mifepristone for endometriosis after laparoscopic conservative surgery.Methods:A retrospective analysis was made in 51 patients with endometriosis who accepted laparoscopic surgery from Sep.2006 to Jun.2008.29 cases underwent treatment of Sanjiezhentong capsule after surgery and 22 cases received Mifepristone.Results:The total effective rate of Sanjiezhentong capsule group was 72.4% and 72.7% in Mifepristone group,the difference was not significant(P0.05).Moreover the conception rate of sterile patients was 31.3% in Sanjiezhentong group and 30.0% in Mifepristone group,the difference was not significant(P0.05).The difference of the recurrence rate in one year was not significant,27.6% in Sanjiezhentong capsule group and 27.3% in Mifepristone group(P0.05).However,the incidence rate of side-effects in Sanjiezhentong capsule group was less than that in Mifepristone group(P0.05).Conclusions:Sanjiezhentong capsule and Mifepristone are effective adjunctive therapies for patients with endometriosis after laparoscopic operation.But Sanjiezhentong capsule avoids side-effect of Mifepristone,guttate hemorrhage,hepatic and renal lesion,and does not significantly affect endocrine.With normal menstruation,patients would like to take Sanjiezhentong capsule which does not affect normal conception.

My notes (saved in your browser only)

Condition tags

endometriosis

Citation neighborhood (no data yet)

We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.

Source provenance

openalex
last seen: 2026-06-10T17:14:06.276822+00:00
License: CC0 · commercial use OK